DDBA 8531 Week 2 Buying Center Map Example

Seminar in B2B Marketing Walden University Free custom sample in 24 to 48h

This DDBA 8531 Week 2 buying center map example places every participant in a western Pennsylvania health system's $4.2 million infusion pump replacement, about 1,350 channels across three hospitals. Walden DDBA 8531 asks students to map who really took part in one purchase and to support each placement with evidence, and the sample's table lists nurses, biomedical engineering, clinical informatics, supply chain, the value analysis committee, the chief financial officer and a pharmacy administrator who controlled vendor access to the drug library. Minutes, a committee charter and interviews show three formal vetoes and several practical ones. Webster and Wind, Johnston and Bonoma, Bonoma and Johnston, and Lilien and Wong frame a DBA map whose overlooked gatekeeper shaped which vendor could compete.

CourseDDBA 8531 Seminar in B2B Marketing
WeekWeek 2
Paper typeBuying center map
LengthAbout 820 words, 5 pages
FormatAPA 7 student paper
SchoolWalden University
ProgramDoctor of Business Administration (DBA)
UpdatedOctober 2026

Free sample paper for DDBA 8531 Week 2

1

Seven Participants, Three Vetoes and One Administrator Nobody Planned For: A Buying Center Map of a Health System's Infusion Pump Replacement, With the Evidence Behind Each Placement

Student Name

Walden University

DDBA 8531: Seminar in B2B Marketing

Instructor Name

Month Day, Year

What this page is doingThe title states the map's main findings, the number of participants and vetoes and the overlooked gatekeeper, so the reader knows what the evidence will show.
2

Seven Participants, Three Vetoes and One Administrator Nobody Planned For: A Buying Center Map of a Health System's Infusion Pump Replacement, With the Evidence Behind Each Placement

The Purchase

A composite three-hospital health system in western Pennsylvania, with 940 licensed beds, replaced its large-volume infusion pumps in 2025. The purchase covered about 1,350 pump channels, software licenses and a seven-year service agreement, at a total of about $4.2 million. Two vendors reached the final evaluation. This paper maps the system's buying center: who took part, what role each played, what test each applied, who could stop the purchase and what evidence supports each placement.

What this page is doingThe map begins with the purchase and its scale, since who takes part depends on what is at stake.
3

The Map

[after]

Evidence came from the value analysis committee's minutes for six meetings, the committee charter, the system's vendor access policy, a published job posting for the informatics lead's position and interviews with the biomedical engineering manager and a nurse educator who sat on the panel.

Table 1

Buying Center for the Infusion Pump Replacement

ParticipantRoleTest appliedVetoEvidence |
Bedside nurses (12 on the evaluation panel)User, influencerProgramming steps, alarm behavior, weight and pole mountingPracticalTrial scorecards, panel roster |
Biomedical engineering managerInfluencer, gatekeeperService terms, parts availability, preventive maintenance hoursPracticalCommittee minutes, interview |
Clinical informatics leadInfluencerWhether pumps send infusion data to the medication recordFormalJob posting, committee minutes |
Supply chain directorBuyerPrice, contract terms, group purchasing pricingNoneContract file |
Value analysis committeeDeciderClinical evidence, total cost, standardizationFormalCommittee charter, minutes |
Chief financial officerDeciderCapital budget fit, payment scheduleFormalCapital plan |
Department administrator, pharmacyGatekeeperVendor access to staff and drug library dataPracticalVendor policy, interview |

Where Roles Overlap

Webster and Wind (1972) described roles as functions in the buying process, not as job titles, so one person can hold several. The biomedical engineering manager was both an influencer, since service terms carried weight in the scoring, and a gatekeeper, since his department controlled which vendor representatives could see the existing pump fleet and its repair history. Nurses were users and influencers at once: their trial scorecards counted for 30 percent of the value analysis committee's weighting.

What this page is doingThe commentary interprets the map rather than restating it, beginning with overlaps.
4

Where Power Differs From Title

Formal authority sat with the value analysis committee and the chief financial officer. But practical vetoes sat elsewhere. The clinical informatics lead's test, whether pumps could exchange data with the medication record, eliminated one vendor's older model early, before the committee scored it. That was a formal veto written into the committee charter, which requires informatics approval for any device that connects to the network. The pharmacy administrator held a practical veto of a different kind: the vendor policy gave pharmacy control over access to the drug library, the list of medications and dose limits programmed into each pump, and one vendor's representatives were refused access for three weeks because they had not completed the required credentialing. Johnston and Bonoma (1981) found that buying centers for important, complex purchases involve more people across more departments and more levels of the organization, and this purchase fits that finding.

The Participant the Seller Met Least

Sellers tend to spend their time with the people whose job is to receive them, usually purchasing staff, while participants elsewhere in the organization go unaddressed. Bonoma and Johnston (1978) argued that industrial buying is a social process among people with different goals and influence, which implies that a seller who meets only one of them sees only part of the decision. The vendor that lost met the supply chain director eleven times and the pharmacy administrator once, according to the system's visitor logs. The winning vendor met pharmacy four times. Nobody planned for the pharmacy administrator to matter, but the drug library is where pump safety is configured, and the administrator controlled the time vendors needed to build it.

Who Talks to Whom

[after]

The biomedical engineering manager was mentioned most often in the minutes, which reflects his position as a link between nursing, informatics and the vendors.

Figure 1

Communication Links Recorded in Committee Minutes

05101520NursesBiomedInformaticsSupply chainCFOPharmacyParticipantMentions in minutes

What the Map Means for a Seller

A seller reading this map would plan its calls differently from one reading the organization chart. The chart shows the supply chain director and the chief financial officer at the center; the map shows that nurses' scorecards, the informatics charter and pharmacy's control of drug library access decided which vendor could compete at all. Contact with each veto holder should be planned for the stage at which that person's test is applied, informatics before the committee scores, pharmacy as soon as credentialing opens.

Limits of the Map

The map rests on documents and two interviews. Minutes record what was said in meetings, not conversations outside them, and the interviews may overstate their subjects' importance. Lilien and Wong (1984) found that buying center involvement varies across stages of the purchase, and this map summarizes the whole process rather than stage by stage.

References

Bonoma, T. V., & Johnston, W. J. (1978). The social psychology of industrial buying and selling. Industrial Marketing Management, 7(4), 213-224. https://doi.org/10.1016/0019-8501(78)90038-x

Johnston, W. J., & Bonoma, T. V. (1981). The buying center: Structure and interaction patterns. Journal of Marketing, 45(3), 143-156. https://doi.org/10.1177/002224298104500312

Lilien, G. L., & Wong, M. A. (1984). An exploratory investigation of the structure of the buying center in the metalworking industry. Journal of Marketing Research, 21(1), 1-11. https://doi.org/10.1177/002224378402100101

Webster, F. E., Jr., & Wind, Y. (1972). A general model for understanding organizational buying behavior. Journal of Marketing, 36(2), 12-19. https://doi.org/10.1177/002224297203600204

Reading the DDBA 8531 Week 2 instructions

Week 2 asks for a map of one organization's buying center for a single purchase. Choose a purchase large enough to involve several departments. Lay out one table line per participating function, and columns for role, the test applied, veto power and the evidence that places the person there, such as minutes, charters, job postings or interviews. Write commentary on three questions: where roles overlap, where practical power differs from formal title and which participant the seller met least often. A simple diagram of communication links helps. Close by stating what the map cannot show, given the documents you used.

How the DDBA 8531 Week 2 example is put together

The sample table has seven rows, from twelve bedside nurses on the evaluation panel to the pharmacy administrator. Tests are specific: programming steps and alarm behavior for nurses, service terms for biomedical engineering, data exchange with the medication record for informatics. The overlap section shows biomedical engineering as both influencer and gatekeeper and nurses' scorecards carrying 30 percent of the weighting. The power section explains how the informatics charter eliminated one vendor's older model early and how pharmacy held off a vendor for three weeks over credentialing. Visitor logs show the losing vendor met supply chain eleven times and pharmacy once, and a chart counts mentions in committee minutes. A limits section notes that minutes miss conversations outside meetings and that interviewees may overstate their own importance, and a closing passage explains how a seller would schedule contact with each veto holder at the stage that person's test applies.

Where the marks sit in the DDBA 8531 Week 2 rubric

Evidence behind each placement carries the most weight; a neat table without sources is a guess. Faculty then read the tests, rewarding those stated as questions a real participant asked over labels such as quality or cost. The veto column earns credit when it separates formal authority from practical power and explains where they diverge. Commentary should interpret rather than repeat the table. The seller-contact analysis shows the map's use to a marketer. Common deductions include omitting a gatekeeper who controls access or scheduling, assigning roles by job title alone and ignoring how membership changed as the purchase moved forward.

Common DDBA 8531 Week 2 mistakes, and how to avoid them

Collect documents before drawing anything. Committee minutes, charters, policies and job postings often reveal who must approve a purchase. Interview one or two participants if you can, and ask who else they had to convince. Remember that one person may hold several roles. When stating tests, use the participant's language: an engineer asks about service response, not value. Look for the person nobody planned for, such as someone who controls access to data or facilities. A small diagram of who spoke to whom can reveal brokers. Acknowledge what your sources miss, such as hallway conversations. Finally, translate the map into advice: whom should a seller meet, and when, given what the map shows?

Get a DDBA 8531 Week 2 example written to your instructions

Pick the purchase, even roughly described, and send it with the Week 2 prompt and rubric. A role table with an evidence column, the commentary and a small influence diagram are drafted inside 24 to 48 hours, at no cost the first time. Placements the sample cannot support from sources are labeled as inferences, not asserted.

More DDBA 8531 papers and DBA samples

DDBA 8531 Week 2 questions, answered

Where can I find a free DDBA 8531 Week 2 sample paper?

Scroll to the paper section for the complete infusion pump map: seven rows, a minutes chart and commentary, all free.

What purchase does the DDBA 8531 Week 2 map cover?

A three-hospital health system's replacement of about 1,350 infusion pump channels for about $4.2 million.

Who was the overlooked gatekeeper?

A pharmacy administrator who controlled vendor access to the drug library that configures each pump.

Which participant held a formal veto by charter?

The clinical informatics lead, who must approve any device that connects to the network.

Where did the evidence come from?

Committee minutes, the committee charter, the vendor access policy, a job posting and two interviews.